Aligos Belgium
Gaston Geenslaan 1/(Gebouw 3)
3001 Leuven
BE
Aligos Belgium
Foundation date
10/09/2018
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
- #Endocrine - nutritional and metabolic diseases
- #Infectious and parasitic diseases
- #Neoplasms / cancer / oncology
ALIGOS BELGIUM is the European branch of Aligos Therapeutics. It's a biotechnology company developing novel therapeutic agents to treat significant liver diseases.
Upcoming events
All events-
0106 '23
KNOWLEDGE FOR GROWTH 2023
Event by: flanders.bio -
0506 '23
BIO International Convention 2023
Event by: Biotechnology Innovation Organisation -
0604 '23
Innovation for Health 2023
Event by: Hyphen Projects
Latest news
More news-
Bimekizumab Phase 3 data in hidradenitis suppurativa show clinically meaningful, deep and maintained response over 48 weeks
Monday March 20th 2023
Read more
-
VIB launches Data Core to support life sciences research
Thursday March 16th 2023
Read more
-
Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease
Thursday March 16th 2023
Read more
Jobs
More jobs-
21/03/23
Flemish Brabant
PhD position - Improved cytogenomic diagnosis in lymphoma: opportunities of optical genome mapping and long-read sequencing.
Temporary
KU Leuven -
21/03/23
Antwerp
Valorisation Manager for the IOF consortium IMARK, IOF platform for image-based biomarkers
Permanent
University of Antwerp -